The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
Alkem introduces cetuximab under the trade name Cetuxa in India.
2.
New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.
3.
Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening
4.
Hybrid imaging test combines antibody and radioisotope for early lung cancer detection
5.
FDA Investigating Blood Cancer Risk With Gene Therapy Skysona
1.
Unlocking the Potential of Ferrotonia: A New Way to Harness Magnetic Energy
2.
Everything You Need To Know About Trichelemmal Cysts: Symptoms, Causes, Diagnosis And Treatment
3.
A Visual Guide to Understanding Breast Cancer Staging
4.
CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma: A Comprehensive Review
5.
Getting to Know RDW and SD: How They Relate to Anemia, Inflammation, and More
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
2.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
3.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation